Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - LU
$ 0.69
-11.5 %
$ 77.8 M
Market Cap
1.35
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
311.76%
EBIT
Estimate
301.57%
Net Income
Estimate
19.42%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Procaps Group S.A.
PROC has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart PROC
EBIT FORECAST
EBIT Forecast Chart PROC
NET INCOME FORECAST
Net Income Chart PROC